Device typeMethotrexate therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA): A collection of reagents and other associated materials intended to be used for the quantitative measurement and therapeutic monitoring of the antineoplastic drug methotrexate in a clinical specimen, using an enzyme immunoassay (EIA) method.
FDA categoryEnzyme Immunoassay, Methotrexate
Device ID00812101030639
Catalog number5026-0001-03
AvailabilityPrescription
Single useYes
MRI safetyLabeling does not contain MRI Safety Information